K Mardanzai

Ruhrlandklinik, University of Duisburg-Essen

Papers

2

Total Citations

167

H-Index

2

About

Dr. K. Mardanzai is a leading thoracic surgeon whose research focuses on advancing minimally invasive surgical techniques for lung cancer, particularly through the application of robotic surgery. His major contributions center on comparative effectiveness research, rigorously evaluating robotic lobectomy against video-assisted thoracoscopic (VATS) and open approaches. His most cited work (125 citations) uses propensity-score adjustment to demonstrate that robotic lobectomy achieves significantly higher rates of pathologic nodal upstaging—a critical measure for accurate staging and adjuvant therapy planning—compared to both VATS and open lobectomy. This finding challenges conventional wisdom and suggests robotic surgery may enable more thorough lymph node dissection. Dr. Mardanzai has also been instrumental in defining the learning curve for robotic thoracic surgery, showing that in high-volume centers, surgeons can achieve proficiency rapidly while maintaining excellent outcomes. His work provides essential evidence for the safe adoption and dissemination of robotic techniques, directly impacting surgical training and patient care standards. By combining rigorous methodology with clinically relevant endpoints, Dr. Mardanzai’s research continues to shape the evolution of lung cancer surgery toward more precise, less invasive approaches.

Research Focus

Key Achievements

2
H-Index
2
Papers
167
Total Citations
84
Avg Citations/Paper
🏆 Most Cited Paper
Propensity-score adjusted comparison of pathologic nodal upstaging by robotic, video-assisted thoracoscopic, and open lobectomy for non–small cell lung cancer
125 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Ruhrlandklinik, University of Duisburg-Essen

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago